http://rdf.ncbi.nlm.nih.gov/pubchem/patent/RU-2440029-C2
Outgoing Links
| Predicate | Object |
|---|---|
| assignee | http://rdf.ncbi.nlm.nih.gov/pubchem/patentassignee/MD5_47c5cd521b5b9c75ff6c0542faea00d7 |
| classificationIPCInventive | http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61B17-00 http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61N5-10 http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61B6-03 http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61K49-06 http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61P35-00 |
| filingDate | 2009-05-13-04:00^^<http://www.w3.org/2001/XMLSchema#date> |
| grantDate | 2012-01-20-04:00^^<http://www.w3.org/2001/XMLSchema#date> |
| inventor | http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_c396af3e0af9ea5a2ffb1a77d7df8ae7 http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_a3d1926c4c0b971cd5e9be0aa0c4f415 http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_382051eaf37a533c41e40bc70975299d http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_8b070f8586398da350c20a92c7db4592 http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_70204338f2ada2d76d6f9ad1662a540d http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_bdd95e40385a2638f8e3c7cdcf72d22d http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_98da096d408aefb36b3f826fdd139221 |
| publicationDate | 2012-01-20-04:00^^<http://www.w3.org/2001/XMLSchema#date> |
| publicationNumber | RU-2440029-C2 |
| titleOfInvention | Early diagnostic technique for postradiation myocardial damage in patients with lung cancer at stages of combination treatment |
| abstract | FIELD: medicine. n SUBSTANCE: invention refers to medicine, oncology and concerns early diagnosis of postradiation myocardial damage in patients suffering lung cancer at the stages of combination treatment by examining a morphofunctional myocardial status. It involves gated myocardial 99m Tc-MIBI SPECT described by two diagnostic criteria: myocardial perfusion values and left ventricular contractility. The criteria are evaluated fivefold: prior to treatment, after 2 courses of neoadjuvant chemotherapy and after 1, 6 and 12 months following a radical surgery with intraoperative radiation therapy. The derived values are compared with the reference values prior to treatment, and if observing a persistent decrease, postradiation myocardial damage is diagnosed. n EFFECT: technique provides adequate assessment of the progression myocardial status, higher diagnostic accuracy and reliability of early postradiation myocardial damages - up to one year prior to treatment in the given group of patients with lung of cancer having an initial considerable risk of development of a cardiac pathology. n 1 ex, 1 app, 2 dwg |
| priorityDate | 2009-05-13-04:00^^<http://www.w3.org/2001/XMLSchema#date> |
| type | http://data.epo.org/linked-data/def/patent/Publication |
Incoming Links
Total number of triples: 25.